These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 23605634)

  • 1. Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.
    Di Paolo A; Gori G; Tascini C; Danesi R; Del Tacca M
    Clin Pharmacokinet; 2013 Jul; 52(7):511-42. PubMed ID: 23605634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of linezolid in plasma/cerebrospinal fluid in patients with cerebral hemorrhage after lateral ventricular drainage by Monte Carlo simulation.
    Wu X; Tang Y; Zhang X; Wu C; Kong L
    Drug Des Devel Ther; 2018; 12():1679-1684. PubMed ID: 29928111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.
    Sullins AK; Abdel-Rahman SM
    Paediatr Drugs; 2013 Apr; 15(2):93-117. PubMed ID: 23529866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low flucloxacillin concentrations in a patient with central nervous system infection: the need for plasma and cerebrospinal fluid drug monitoring in the ICU.
    Abdul-Aziz MH; McDonald C; McWhinney B; Ungerer JP; Lipman J; Roberts JA
    Ann Pharmacother; 2014 Oct; 48(10):1380-4. PubMed ID: 24951308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.
    Singh J; Burr B; Stringham D; Arrieta A
    Paediatr Drugs; 2001; 3(10):733-61. PubMed ID: 11706924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
    Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.
    Nau R; Sörgel F; Prange HW
    Clin Pharmacokinet; 1998 Sep; 35(3):223-46. PubMed ID: 9784935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of intravenous moxifloxacin in the cerebrospinal fluid of a patient with central nervous system shunt infection.
    Zhang B; Huang X; Fan H; Zeng X; Mei D; Fu Q
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):249-51. PubMed ID: 26746981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration alone in intracranial infections.
    Ni M; Zhao L; Zhang WJ; Ma JW; Zhang GY; Cui DM; Wang K; Fei YB; Gao L; Shen FM
    Int J Antimicrob Agents; 2021 Mar; 57(3):106281. PubMed ID: 33465459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review.
    Beach JE; Perrott J; Turgeon RD; Ensom MHH
    Clin Pharmacokinet; 2017 Dec; 56(12):1479-1490. PubMed ID: 28528396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal Antibacterial and Antifungal Therapies.
    Nau R; Blei C; Eiffert H
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32349999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.
    Benitez-Del-Castillo J; Verboven Y; Stroman D; Kodjikian L
    Clin Drug Investig; 2011; 31(8):543-557. PubMed ID: 21604820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
    Roberts JA; Lipman J
    Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy.
    Chen K; Wu Y; Wang Q; Wang J; Li X; Zhao Z; Zhou J
    J Crit Care; 2015 Feb; 30(1):218.e1-5. PubMed ID: 25449880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interethnic differences in pharmacokinetics of antibacterials.
    Tsai D; Jamal JA; Davis JS; Lipman J; Roberts JA
    Clin Pharmacokinet; 2015 Mar; 54(3):243-60. PubMed ID: 25385446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.
    Ulldemolins M; Roberts JA; Rello J; Paterson DL; Lipman J
    Clin Pharmacokinet; 2011 Feb; 50(2):99-110. PubMed ID: 21142293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kinetic analysis of the disposition of hydrophilic drugs in the central nervous system (CNS): prediction of the CNS disposition from the transport properties in the blood-brain and blood-cerebrospinal fluid barriers].
    Suzuki H; Sugiyama Y
    Yakugaku Zasshi; 1994 Dec; 114(12):950-71. PubMed ID: 7869236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid in the central nervous system: comparison between cerebrospinal fluid and plasma pharmacokinetics.
    Viaggi B; Paolo AD; Danesi R; Polillo M; Ciofi L; Del Tacca M; Malacarne P
    Scand J Infect Dis; 2011 Sep; 43(9):721-7. PubMed ID: 21585240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacodynamics of antibiotics in CSF: principles and consequences (predictive factors of efficacy)].
    Van Bambeke F; Tulkens PM
    Med Mal Infect; 2009; 39(7-8):483-92. PubMed ID: 19500928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic pharmacodynamics in cerebrospinal fluid.
    Lutsar I; McCracken GH; Friedland IR
    Clin Infect Dis; 1998 Nov; 27(5):1117-27, quiz 1128-9. PubMed ID: 9827256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.